Eli Lilly and Company

Eli Lilly's third-quarter results significantly exceeded expectations, prompting an upward revision of its full-year guidance. Shares surged 5% in pre-market trading.

①Eli Li Third-quarter revenue was $17.6 billion, up 54% year-over-year, with adjusted earnings per share of $7.02, far ...

Stock
2026-01-12